Ligand validation:6T16

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 6T16 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6T16_GLC_A_1504	62%	48%	0.132	0.941	0.68	1.32	-	2	1	0	92%	0.9167
6T16_GLC_A_1503	52%	61%	0.164	0.939	0.73	0.75	-	-	1	0	92%	0.9167
6T16_GLC_A_1508	49%	33%	0.17	0.916	0.47	2.24	-	6	3	0	100%	1
6T16_GLC_A_1505	33%	66%	0.178	0.854	0.53	0.74	-	-	1	0	100%	1
6T16_GLC_B_1504	21%	62%	0.222	0.847	0.61	0.83	-	-	0	0	92%	0.9167
6T16_GLC_A_1501	17%	70%	0.288	0.864	0.51	0.62	-	-	0	0	100%	1
6SYQ_GLC_A_1505	31%	40%	0.187	0.871	0.98	1.42	1	3	0	0	92%	0.9167
5MTT_GLC_A_407	98%	65%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.66	1.02	-	1	0	0	100%	1
2JJB_GLC_D_1548	98%	55%	0.07	0.989	0.73	1	-	2	0	0	100%	1
6LGB_GLC_A_704	97%	60%	0.066	0.984	0.56	0.95	-	1	0	0	100%	1
4AD2_GLC_A_500	97%	51%	0.052	0.984	0.61	1.26	-	1	1	0	92%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.